The New York Times examines a set of questions raised by news out of the International AIDS Conference-AIDS 2010 last week that a microbicide gel containing the antiretroviral (ARV) tenofovir used by women before and after sex helped reduce their risk of HIV infection by 39 percent. “After more than a dozen microbicide failures, [the news of the trial] was a huge relief …
Related posts:
on
No Comments on “New York Times Examines Questions Left Unanswered By Microbicide Trial”
You can track this conversation through its atom feed.